Skip to content

ECUPHAR

Active
Public limited companyfounded 200124 yrs activeLegeweg 157, 8020 Oostkamp, BelgiumKBO/BCE: BE 0476.255.350
Summary

ECUPHAR has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €83.3m and a net result of €1.6m. Equity is shrinking by ~2.7% per year across the filed fiscal years. Its solvency ranks better than 57% of 712 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability49▼-14
Solvency76▲+12
Growth37▼-31
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 3.03 against 0.76 in 2024; short-term debt: 10.4% and cash: 1.1% of total assets), and 49.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
50.8%
Return on assets
1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 24 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
on the day
2024
6 d early
2023
26 d early
2022
134 d late
2021
78 d late
2020
262 d late
2019
35 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 58 days after the deadline; the sector median for financial year 2024 is 6 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ECUPHAR was incorporated on 6 December 2001.1 The registered office was moved to Zedelgem in 2005.2 Between 2006 and 2017 the capital was increased 6 times, most recently to EUR 13 million.345 In 2006 the company absorbed Ecuphar by merger.6 The board currently has 2 members; Christopher Brewster has served longest, since 2023.7 Revenue grew from EUR 18 million in 2018 to EUR 23 million in 2025 and headcount from 19.4 to 21.4 full-time equivalents.8

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 28-11-2005
  3. 3Belgian State Gazette, 24-04-2006
  4. 4Belgian State Gazette, 07-12-2015
  5. 5Belgian State Gazette, 04-08-2017
  6. 6Belgian State Gazette, 13-11-2006
  7. 7Belgian State Gazette, 03-07-2024
  8. 8National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema, statutory accounts

Turnover
€22.9m▼ 1.5%
2024 · €23.2m
EBIT margin
8.8%▲ 1.5pp
2024 · 7.3%
Net result
€1.6m▼ 95.5%
2024 · €36.1m
Working capital
€34.7m
2024 · -€29.4m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 73, Advertising, market research and public relations activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€18.6m▼ 2.3%€17.8m▼ 4.4%€21.3m▲ 19.9%€23.2m▲ 9.0%€22.9m▼ 1.5%
Operating result€1.5m€240,986▼ 83.8%€973,158▲ 304%€1.7m▲ 74.6%€2.0m▲ 19.0%
Net result€342,703above the sector's middle half-€2.9mbelow the sector's middle half€7.7mabove the sector's middle half€36.1mabove the sector's middle half▲ 366%€1.6mabove the sector's middle half▼ 95.5%
EBIT margin8.0%▲ 26.6pp1.4%▼ 6.7pp4.6%▲ 3.2pp7.3%▲ 2.8pp8.8%▲ 1.5pp
Equity€67.7mabove the sector's middle half▼ 11.9%€64.9mabove the sector's middle half▼ 4.3%€68.6mabove the sector's middle half▲ 5.8%€94.7mabove the sector's middle half▲ 38.0%€83.3mabove the sector's middle half▼ 12.0%
Total assets€137.4mabove the sector's middle half▲ 20.2%€148.7mabove the sector's middle half▲ 8.2%€161.8mabove the sector's middle half▲ 8.8%€241.0mabove the sector's middle half▲ 48.9%€164.1mabove the sector's middle half▼ 31.9%
Debt€69.7m▲ 86.1%€83.7m▲ 20.2%€93.2m▲ 11.3%€146.4m▲ 57.0%€80.8m▼ 44.8%
Working capital-€4.5m-€2.9m▲ 34.5%-€3.3m▼ 12.2%-€29.4m▼ 795%€34.7m
Solvency49.3%within the sector's middle half▼ 18.0pp43.6%within the sector's middle half▼ 5.7pp42.4%within the sector's middle half▼ 1.2pp39.3%within the sector's middle half▼ 3.1pp50.8%within the sector's middle half▲ 11.5pp
Staff (FTE)22.1above the sector's middle half▲ 5.7%21.5above the sector's middle half▼ 2.7%19.8above the sector's middle half▼ 7.9%21.1above the sector's middle half▲ 6.6%21.4above the sector's middle half▲ 1.4%
above within below the middle half (P25 to P75) of NACE 73, Advertising, market research and public relations activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€10.0m€0€10.0m€20.0m€30.0m€40.0mOperating result 2021: €1.5m€1.5mNet result 2021: €342,703€342,703Operating result 2022: €240,986€240,986Net result 2022: -€2.9m-€2.9mOperating result 2023: €973,158€973,158Net result 2023: €7.7m€7.7mOperating result 2024: €1.7m€1.7mNet result 2024: €36.1m€36.1mOperating result 2025: €2.0m€2.0mNet result 2025: €1.6m€1.6m20212022202320242025€0€10m€20m€30m€40mOperating result 2023: €973,158€973,000Net result 2023: €7.7m€7.7mOperating result 2024: €1.7m€1.7mNet result 2024: €36.1m€36mOperating result 2025: €2.0m€2mNet result 2025: €1.6m€1.6m202320242025
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 19% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €164.1m
Fixed assets €112.4m ▼ 24.0%
Current assets €51.8m ▼ 44.4%
Equity and liabilities €164.1m
Equity €83.3m ▼ 12.0%
Debt €80.8m ▼ 44.8%
Debt's share of the balance-sheet total falls from 60.7% to 49.2%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€4.2m▼
2024 · €5.2m
Cash flow
€3.8m▼
2024 · €39.6m
Current ratio
3.03▲
2024 · 0.76
Quick ratio
2.93▲
2024 · 0.74
Debt to equity
0.97▼
2024 · 1.55
ROE
2.0%▼
2024 · 38.1%
ROA
1.0%▼
2024 · 15.0%
Interest coverage
0.73▼
2024 · 0.85
Debt ≤ 1 year
€17.1m▼
2024 · €122.5m
Debt > 1 year
€63.7m▲
2024 · €23.8m
Income taxes
€5,223▼
2024 · €11,460
Staff costs
€2.4m▼
2024 · €2.5m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 94 lines
Balance sheet Code20242025
Assets
Total assets20/58€241.0m€164.1m▼
Fixed assets21/28€147.9m€112.4m▼
Intangible fixed assets21€5.5m€6.5m▲
Tangible fixed assets22/27€4,498€8,187▲
Plant, machinery and equipment23€0-
Furniture and vehicles24€4,498€8,187▲
Assets under construction and advance payments27€0-
Financial fixed assets28€142.4m€105.8m▼
Affiliated companies280/1€142.4m€105.8m▼
Participating interests280€66.0m€105.8m▲
Amounts receivable281€76.4m€0▼
Other financial fixed assets284/8€914€914=
Amounts receivable and cash guarantees285/8€914€914=
Current assets29/58€93.1m€51.8m▼
Amounts receivable after more than one year29€0€31.0m▲
Other amounts receivable291€0€31.0m▲
Stocks and contracts in progress3€2.0m€1.6m▼
Stocks30/36€2.0m€1.6m▼
Raw materials and consumables30/31€440,365€344,503▼
Goods purchased for resale34€1.5m€1.3m▼
Amounts receivable within one year40/41€77.9m€17.0m▼
Trade receivables40€8.3m€10.2m▲
Other amounts receivable41€69.6m€6.8m▼
Cash at bank and in hand54/58€12.9m€1.7m▼
Deferred charges and accrued income490/1€378,855€338,550▼
Equity and liabilities
Total equity and liabilities10/49€241.0m€164.1m▼
Equity10/15€94.7m€83.3m▼
Contributions10/11€37.2m€37.2m=
Capital10€13.0m€13.0m=
Issued capital100€13.0m€13.0m=
Outside capital11€24.2m€24.2m=
Share premium1100/10€24.2m€24.2m=
Reserves13€57.5m€46.1m▼
Non-distributable reserves130/1€1.3m€1.3m=
Legal reserve130€1.3m€1.3m=
Distributable reserves133€56.2m€44.8m▼
Amounts payable17/49€146.4m€80.8m▼
Amounts payable after more than one year17€23.8m€63.7m▲
Financial debts170/4€23.8m€11.3m▼
Credit institutions173€23.8m€11.3m▼
Other amounts payable178/9-€52.4m
Amounts payable within one year42/48€122.5m€17.1m▼
Current portion of amounts payable after more than one year42€1.2m€2.4m▲
Trade debts44€4.9m€6.4m▲
Suppliers440/4€4.9m€6.4m▲
Advances received on contracts in progress46€39,719€0▼
Taxes, remuneration and social security45€509,457€523,955▲
Taxes450/3€0€21,807▲
Remuneration and social security454/9€509,457€502,148▼
Other amounts payable47/48€115.9m€7.8m▼
Accrued charges and deferred income492/3€18,850€51,877▲
Income statement Code20242025
Operating income70/76A€24.0m€23.5m▼
Turnover70€23.2m€22.9m▼
Own construction capitalised72€196,904€200,859▲
Other operating income74€88,771€54,435▼
Non-recurring operating income76A€515,467€415,430▼
Operating charges60/66A€22.3m€21.5m▼
Goods for resale, raw materials and consumables60€5.8m€6.1m▲
Purchases600/8€6.1m€5.7m▼
Change in stocks: decrease (increase)609-€293,991€362,937▲
Services and other goods61€10.3m€10.5m▲
Remuneration, social security and pensions62€2.5m€2.4m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.5m€2.2m▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€64,369-€16,445▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€0-
Other operating charges640/8€5,629€7,042▲
Non-recurring operating charges66A€141,988€435,990▲
Operating profit (loss)9901€1.7m€2.0m▲
Financial income75/76B€43.5m€9.8m▼
Recurring financial income75€40.7m€9.7m▼
Income from financial fixed assets750€35.3m€1.0m▼
Income from current assets751€5.2m€4.8m▼
Other financial income752/9€146,834€3.9m▲
Non-recurring financial income76B€2.8m€20,860▼
Financial charges65/66B€9.1m€10.1m▲
Recurring financial charges65€9.1m€10.1m▲
Debt charges650€6.1m€5.8m▼
Other financial charges652/9€3.0m€4.3m▲
Non-recurring financial charges66B€0€0▼
Profit (loss) for the period before taxes9903€36.1m€1.6m▼
Income taxes67/77€11,460€5,223▼
Taxes670/3€354,319€5,223▼
Tax adjustments and reversals of tax provisions77€342,859€0▼
Profit (loss) for the period9904€36.1m€1.6m▼
Profit (loss) for the period to be appropriated9905€36.1m€1.6m▼
Appropriation of the result
Profit (loss) to be appropriated9906€36.1m€1.6m▼
Transfer from equity791/2€0€11.4m▲
From reserves792€0€11.4m▲
Transfer to equity691/2€26.1m€0▼
To the legal reserve6920€103,373€0▼
To other reserves6921€26.0m€0▼
Profit to be distributed694/7€10.0m€13.0m▲
Return on contributions (dividend)694€10.0m€13.0m▲
Social balance
Average headcount (FTE)908721.121.4▲

The notes to these accounts (98 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€19.2m€18.1m€21.5m€24.0m€23.5m▼ 1.9%
Turnover70€18.6m€17.8m€21.3m€23.2m€22.9m▼ 1.5%
Own construction capitalised72€15,410€15,345€78,940€196,904€200,859▲ 2.0%
Other operating income74€54,551€70,085€99,482€88,771€54,435▼ 38.7%
Non-recurring operating income76A€584,340€247,879€0€515,467€415,430▼ 19.4%
Operating charges60/66A€17.8m€17.9m€20.5m€22.3m€21.5m▼ 3.5%
Goods for resale, raw materials and consumables60€5.2m€4.2m€4.8m€5.8m€6.1m▲ 4.4%
Purchases600/8€4.6m€4.0m€5.2m€6.1m€5.7m▼ 6.6%
Change in stocks: decrease (increase)609€597,684€190,676-€476,596-€293,991€362,937▲ 223%
Services and other goods61€7.6m€8.1m€9.8m€10.3m€10.5m▲ 1.4%
Remuneration, social security and pensions62€1.6m€1.9m€2.1m€2.5m€2.4m▼ 3.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.4m€3.3m€3.4m€3.5m€2.2m▼ 37.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€64,284-€91,626€24,398€64,369-€16,445▼ 126%
Provisions for liabilities and charges: additions (uses and reversals)635/8€18,900€109,735-€128,635€0--
Other operating charges640/8€1,010€7,322€4,323€5,629€7,042▲ 25.1%
Non-recurring operating charges66A€22,263€422,512€521,070€141,988€435,990▲ 207%
Operating profit (loss)9901€1.5m€240,986€973,158€1.7m€2.0m▲ 19.0%
Financial income75/76B€1.6m€3.5m€12.1m€43.5m€9.8m▼ 77.6%
Recurring financial income75€1.6m€3.5m€12.1m€40.7m€9.7m▼ 76.1%
Income from financial fixed assets750-€1.8m€8.2m€35.3m€1.0m▼ 97.2%
Income from current assets751€464,080€882,645€3.1m€5.2m€4.8m▼ 7.6%
Other financial income752/9€1.2m€845,473€768,401€146,834€3.9m▲ 2,588%
Non-recurring financial income76B€0--€2.8m€20,860▼ 99.3%
Financial charges65/66B€2.8m€6.6m€5.3m€9.1m€10.1m▲ 11.2%
Recurring financial charges65€2.7m€2.0m€5.3m€9.1m€10.1m▲ 11.2%
Debt charges650€457,457€1.6m€4.5m€6.1m€5.8m▼ 5.7%
Other financial charges652/9€2.2m€412,022€764,454€3.0m€4.3m▲ 46.3%
Non-recurring financial charges66B€122,706€4.7m€17,138€0€0▼ 100%
Profit (loss) for the period before taxes9903€342,703-€2.9m€7.7m€36.1m€1.6m▼ 95.4%
Income taxes67/77€0€3,003€7,554€11,460€5,223▼ 54.4%
Taxes670/3€0€3,745€7,554€354,319€5,223▼ 98.5%
Tax adjustments and reversals of tax provisions77-€742€0€342,859€0▼ 100%
Profit (loss) for the period9904€342,703-€2.9m€7.7m€36.1m€1.6m▼ 95.5%
Profit (loss) for the period to be appropriated9905€342,703-€2.9m€7.7m€36.1m€1.6m▼ 95.5%
Line20212022202320242025Change
Assets
Total assets20/58€137.4m€148.7m€161.8m€241.0m€164.1m▼ 31.9%
Fixed assets21/28€84.0m€77.8m€75.4m€147.9m€112.4m▼ 24.0%
Intangible fixed assets21€11.3m€9.9m€7.4m€5.5m€6.5m▲ 18.8%
Tangible fixed assets22/27€33,264€7,142€17,553€4,498€8,187▲ 82.0%
Plant, machinery and equipment23€4,882€1,153€9€0--
Furniture and vehicles24€11,561€5,919€12,159€4,498€8,187▲ 82.0%
Other tangible fixed assets26€1,410€69€0---
Assets under construction and advance payments27€15,410€0€5,385€0--
Financial fixed assets28€72.6m€67.9m€67.9m€142.4m€105.8m▼ 25.7%
Affiliated companies280/1€72.6m€67.9m€67.9m€142.4m€105.8m▼ 25.7%
Participating interests280€72.6m€67.9m€67.9m€66.0m€105.8m▲ 60.3%
Amounts receivable281---€76.4m€0▼ 100%
Other financial fixed assets284/8€714€714€914€914€914=
Amounts receivable and cash guarantees285/8€714€714€914€914€914=
Current assets29/58€53.4m€70.9m€86.5m€93.1m€51.8m▼ 44.4%
Amounts receivable after more than one year29€4.4m€4.4m€4.4m€0€31.0m-
Other amounts receivable291€4.4m€4.4m€4.4m€0€31.0m-
Stocks and contracts in progress3€1.4m€1.3m€1.7m€2.0m€1.6m▼ 17.6%
Stocks30/36€1.4m€1.3m€1.7m€2.0m€1.6m▼ 17.6%
Raw materials and consumables30/31€330,954€318,388€270,052€440,365€344,503▼ 21.8%
Goods purchased for resale34€1.1m€968,552€1.5m€1.5m€1.3m▼ 16.4%
Amounts receivable within one year40/41€42.3m€59.4m€76.7m€77.9m€17.0m▼ 78.1%
Trade receivables40€7.8m€13.4m€6.9m€8.3m€10.2m▲ 23.7%
Other amounts receivable41€34.5m€46.0m€69.8m€69.6m€6.8m▼ 90.2%
Cash at bank and in hand54/58€5.4m€5.6m€3.4m€12.9m€1.7m▼ 86.5%
Deferred charges and accrued income490/1€0€191,951€245,918€378,855€338,550▼ 10.6%
Equity and liabilities
Total equity and liabilities10/49€137.4m€148.7m€161.8m€241.0m€164.1m▼ 31.9%
Equity10/15€67.7m€64.9m€68.6m€94.7m€83.3m▼ 12.0%
Contributions10/11€37.2m€37.2m€37.2m€37.2m€37.2m=
Capital10€13.0m€13.0m€13.0m€13.0m€13.0m=
Issued capital100€13.0m€13.0m€13.0m€13.0m€13.0m=
Outside capital11€24.2m€24.2m€24.2m€24.2m€24.2m=
Share premium1100/10€24.2m€24.2m€24.2m€24.2m€24.2m=
Reserves13€30.5m€27.6m€31.4m€57.5m€46.1m▼ 19.8%
Non-distributable reserves130/1€1.2m€1.2m€1.2m€1.3m€1.3m=
Legal reserve130€1.2m€1.2m€1.2m€1.3m€1.3m=
Distributable reserves133€29.3m€26.5m€30.2m€56.2m€44.8m▼ 20.2%
Provisions and deferred taxes16€18,900€128,635€0---
Provisions for liabilities and charges160/5€18,900€128,635€0---
Other liabilities and charges164/5€18,900€128,635€0---
Amounts payable17/49€69.7m€83.7m€93.2m€146.4m€80.8m▼ 44.8%
Amounts payable after more than one year17€11.6m€9.9m€3.4m€23.8m€63.7m▲ 167%
Financial debts170/4€11.6m€9.9m€3.4m€23.8m€11.3m▼ 52.6%
Credit institutions173€11.6m€9.9m€3.4m€23.8m€11.3m▼ 52.6%
Other amounts payable178/9----€52.4m-
Amounts payable within one year42/48€57.9m€73.8m€89.8m€122.5m€17.1m▼ 86.0%
Current portion of amounts payable after more than one year42€0€0-€1.2m€2.4m▲ 106%
Trade debts44€8.3m€7.2m€4.3m€4.9m€6.4m▲ 29.2%
Suppliers440/4€8.3m€7.2m€4.3m€4.9m€6.4m▲ 29.2%
Advances received on contracts in progress46---€39,719€0▼ 100%
Taxes, remuneration and social security45€527,809€454,275€560,619€509,457€523,955▲ 2.8%
Taxes450/3€742€0€1€0€21,807▲ 13,629,394%
Remuneration and social security454/9€527,067€454,275€560,618€509,457€502,148▼ 1.4%
Other amounts payable47/48€49.1m€66.1m€84.9m€115.9m€7.8m▼ 93.3%
Accrued charges and deferred income492/3€165,169€72,324€102,791€18,850€51,877▲ 175%
Line20212022202320242025Change
Profit (loss) for the period9904€342,703-€2.9m€7.7m€36.1m€1.6m▼ 95.5%
+ Depreciation and write-downs630€3.4m€3.3m€3.4m€3.5m€2.2m▼ 37.7%
Operating cash flow (approximation)€3.7m€398,275€11.2m€39.6m€3.8m▼ 90.3%
Investment in fixed assets (approximation)-€2.9m-€930,876-€76.1m€33.4m▲ 144%
Change in cash-€243,759-€2.2m€9.5m-€11.1m▼ 218%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
22-01
State Gazette act Purpose
Purpose change2 facts ▸
  • General meeting, 12 januari 2026
  • Purpose change, De vennootschap heeft tot voorwerp, in België en in het buitenland, zowel voor eigen rekening als voor rekening van derden, of door deelname aan dezen: - het ui…
2025
31-12
Financial Liquidity quadruplescurrent ratio 3.03
Current ratio from 0.76 to 3.03; short-term debt falls from €122.5m to €17.1m.
25-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Highest result since 2018net €36.1m ▲366%
Net result €36.1m, the highest in the series.
02-12
State Gazette act Appointment: Grant Thornton Bedrijfsrevisoren (statutory auditor)
Permanent representative: Elie Janssens3 facts ▸
  • General meeting, 04/09/2024
  • Auditor appointment, Grant Thornton Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Elie Janssens (permanent representative)
05-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
03-07
State Gazette act Appointments: Christopher Brewster (director) and Jennifer Winter (director)
4 facts ▸
  • General meeting, 11/12/2023
  • Director appointment, Christopher Brewster (director)
  • General meeting, 23/04/2024
  • Director appointment, Jennifer Winter (director)
2023
31-12
Financial Back to profitnet €7.7m
Net result €7.7m after one loss-making year.
12-12
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 134 days late
2022
12-12
State Gazette act Appointment: PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Wouter Coppens3 facts ▸
  • General meeting, 15/03/2022
  • Auditor appointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Wouter Coppens
17-10
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 78 days late
Show earlier events
12-09
State Gazette act Resignations & appointments
Power of attorney3 facts ▸
  • Board meeting, 23-08-2022
  • Power of attorney, Winand Kissels
  • Power of attorney, Bas van Dijk
19-04
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 262 days late
2021
31-12
Financial Back to profitnet €342,703
Net result €342,703 after 2 loss-making years.
27-05
State Gazette act Resignations & appointments
Power of attorney4 facts ▸
  • Board meeting, 08/09/2020
  • Board meeting, 10/05/2021
  • Power of attorney, Simeon De Maertelaere
  • Power of attorney, Winand Kissels
2020
08-09
State Gazette act Resignation: MADDENS Sara Tina (director)
Statutes amendment · Capital4 facts ▸
  • General meeting, 11 augustus 2020
  • Director resignation, MADDENS Sara Tina (director)
  • Statutes amendment
  • Capital, €12.967.260,46
26-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Weakest financial yearnet -€6.8m
Net result drops to -€6.8m, the lowest in the series; recovery starts the following year.
22-10
State Gazette act Resignation: F.F.F. BVBA (director)
Permanent representative: Christiaan Cardon · Power of attorney4 facts ▸
  • General meeting, 26/07/2019
  • Director resignation, F.F.F. BVBA (director)
  • Permanent representative, Christiaan Cardon
  • Power of attorney, Bart Vanderstraete
24-09
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 55 days late
26-08
State Gazette act Resignation: Business Contact International BVBA (director)
Appointment: Sara MADDENS (director) · Permanent representatives: Jeroen BASTIJNS and Christiaan CARDON · Power of attorney9 facts ▸
  • General meeting, 14/06/2019
  • Director resignation, Business Contact International BVBA (director)
  • Director appointment, Sara MADDENS (director)
  • Permanent representative, Jeroen BASTIJNS
  • Permanent representative, Christiaan CARDON
  • Power of attorney, Bart Vanderstraete
  • Power of attorney, Amaury de Borchgrave d'Altena
  • Power of attorney, Evelyne Kerkdijk
  • Power of attorney, Kety Tsochas
02-01
State Gazette act Appointment: Jenny Winter (director)
Permanent representatives: Christiaan Cardon and Jeroen Bastijns4 facts ▸
  • General meeting, 02/11/2018
  • Director appointment, Jenny Winter (director)
  • Permanent representative, Christiaan Cardon
  • Permanent representative, Jeroen Bastijns
2018
14-12
NBB filing Annual accounts filed
fiscal year 2017 · consolidated
04-09
State Gazette act Resignation: Iain Menneer (director)
Appointment: BCVBA PwC Bedrijfsrevisoren (statutory auditor) · Permanent representatives: Peter Opsomer, Christiaan Cardon and Jeroen Bastijns7 facts ▸
  • Board meeting, 08/06/2018
  • Director resignation, Iain Menneer (director)
  • Auditor appointment, BCVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Peter Opsomer
  • Permanent representative, Christiaan Cardon
  • Permanent representative, Jeroen Bastijns
  • Director resignation, statutory auditor
08-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
29-12
State Gazette act Resignation: Asara BVBA (director)
Permanent representatives: Walter BEYERS, Christiaan Cardon and Jeroen Bastijns · Appointment: Chris BREWSTER (director)6 facts ▸
  • General meeting, 01/12/2017
  • Director resignation, Asara BVBA (director)
  • Permanent representative, Walter BEYERS
  • Director appointment, Chris BREWSTER (director)
  • Permanent representative, Christiaan Cardon
  • Permanent representative, Jeroen Bastijns
04-08
State Gazette act Capital & shares · Statutes amendment
Share cancellation · Warrant cancellation6 facts ▸
  • General meeting, 07/07/2017
  • Share cancellation, 216280, 13957720
  • Warrant cancellation, 705700, cancellation
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
04-08
State Gazette act Resignations: MYLECKE MANAGEMENT, ART & INVEST, MICHAEL SCHENCK and 2 others
Permanent representatives: Marc COUCKE, Michael SCHENCK and 3 others · Appointments: F.F.F., BUSINESS CONTACT INTERNATIONAL and 2 others · Statutes amendment21 facts ▸
  • General meeting, 13/07/2017
  • Statutes amendment
  • Director resignation, MYLECKE MANAGEMENT, ART & INVEST (director)
  • Permanent representative, Marc COUCKE
  • Director resignation, MICHAEL SCHENCK (director)
  • Permanent representative, Michael SCHENCK
  • Director resignation, BELLEVUE (director)
  • Permanent representative, Christiaan CARDON
  • Director resignation, BUSINESS CONTACT INTERNATIONAL (director)
  • Permanent representative, Jeroen BASTIJNS
  • Director appointment, F.F.F. (director)
  • Permanent representative, Christiaan CARDON
  • +9 further facts in this act
04-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Power of attorney4 facts ▸
  • General meeting, 19/07/2017
  • Capital increase, €3.909.690,46
  • Statutes amendment
  • Power of attorney, Guillaume ELLEBOUDT
2016
23-09
State Gazette act Resignation: Alychlo NV (a bestuurder)
Permanent representatives: BDS Management BVBA, Barbara De Saedeleer and 2 others · Appointments: Michael Schenck BVBA (a bestuurder) and Mylecke Management, Art & Invest NV (chair of the board)9 facts ▸
  • Board meeting, 31/08/2016
  • Director resignation, Alychlo NV (a bestuurder)
  • Director resignation, Alychlo NV (chair of the board)
  • Permanent representative, BDS Management BVBA
  • Permanent representative, Barbara De Saedeleer
  • Director appointment, Michael Schenck BVBA (a bestuurder)
  • Permanent representative, Michael Schenck
  • Director appointment, Mylecke Management, Art & Invest NV (chair of the board)
  • Permanent representative, Marc Coucke
22-08
State Gazette act Permanent representatives: Chris Cardon and Jeroen Bastijns
Share cancellation · Capital · Statutes amendment6 facts ▸
  • Board meeting, 14/07/2016
  • Share cancellation, 216.280
  • Capital, €9.057.570
  • Statutes amendment
  • Permanent representative, Chris Cardon
  • Permanent representative, Jeroen Bastijns
2015
29-12
State Gazette act Resignations: Jeroen Bastijns (director) and Christiaan Cardon (director)
Permanent representatives: Christiaan Cardon and Jeroen Bastijns5 facts ▸
  • Board meeting, 25/11/2015
  • Director resignation, Jeroen Bastijns (director)
  • Director resignation, Christiaan Cardon (director)
  • Permanent representative, Christiaan Cardon
  • Permanent representative, Jeroen Bastijns
17-12
State Gazette act Appointments: PricewaterhouseCoopers Bedrijfsrevisoren, ALYCHLO and 3 others
Resignation: SAM SABBE (director) · Permanent representatives: Sam SABBE, BDS Management and 4 others · Statutes amendment21 facts ▸
  • General meeting, 24-11-2015
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Share issue, warranten, 705700
  • Approval, Warrantenplan
  • Director resignation, SAM SABBE (director)
  • Permanent representative, Sam SABBE
  • Director appointment, ALYCHLO (director)
  • Permanent representative, BDS Management
  • Permanent representative, Barbara DE SAEDELEER
  • +9 further facts in this act
07-12
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment4 facts ▸
  • Board meeting, 26/10/2015
  • Capital increase, €53.250
  • Capital, €9.057.570
  • Statutes amendment
17-08
State Gazette act Resignation: Finipan NV (director)
1 fact ▸
  • Director resignation, Finipan NV (director)
06-08
State Gazette act Capital & shares
Capital increase · Bank account · Statutes amendment5 facts ▸
  • Board meeting, 15/07/2015
  • Capital increase, €2.850.000
  • Bank account, 15/07/2015
  • Statutes amendment
  • Preemptive rights lift
2013
27-11
State Gazette act Appointments: Finipan (director) and Christiaan Cardon (managing director)
Permanent representatives: Joost Van Cauwenberge and Sam Sabbe · Reappointment: Sam Sabbe (director)7 facts ▸
  • General meeting, 14/06/2013
  • Director appointment, Finipan (director)
  • Permanent representative, Joost Van Cauwenberge
  • Director reappointment, Sam Sabbe (director)
  • Permanent representative, Sam Sabbe
  • Board meeting, 23/08/2011
  • Director appointment, Christiaan Cardon (managing director)
27-06
State Gazette act Appointment: BVBA Van Cauter -Saeys & Co (statutory auditor)
Permanent representative: Willem Van Cauter3 facts ▸
  • General meeting, 08/06/2012
  • Auditor appointment, BVBA Van Cauter -Saeys & Co (statutory auditor)
  • Permanent representative, Willem Van Cauter
03-04
State Gazette act Algemene Vergadering
Capital decrease · Capital · Statutes amendment7 facts ▸
  • General meeting, 01/03/2013
  • Capital decrease, €6.039.280
  • Capital, €6.154.320
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, raad van bestuur
  • Capital distribution, 6.039.280,00 €
2012
06-08
State Gazette act Algemene Vergadering
Capital decrease · Capital · Statutes amendment5 facts ▸
  • General meeting, 13/07/2012
  • Capital decrease, €6.039.280
  • Capital, €6.154.320
  • Statutes amendment
  • Statutes amendment
12-06
State Gazette act Capital & shares
Capital increase · Capital2 facts ▸
  • Capital increase, €273.350
  • Capital, €12.193.600
2011
14-09
State Gazette act Reappointments: Christiaan Cardon (director) and Jeroen Bastijns (director)
3 facts ▸
  • General meeting, 10/06/2011
  • Director reappointment, Christiaan Cardon (director)
  • Director reappointment, Jeroen Bastijns (director)
04-07
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment4 facts ▸
  • Board meeting, 27.05.2011
  • Capital increase, €237.850
  • Capital, €11.920.250
  • Statutes amendment
04-03
State Gazette act Resignation: Tom Almey (director)
1 fact ▸
  • Director resignation, Tom Almey (director)
2010
10-12
State Gazette act Capital & shares · Restructuring
Merger · Share cancellation3 facts ▸
  • General meeting, 22.11.2010
  • Merger, geruisloze fusie
  • Share cancellation, 750
05-10
State Gazette act Restructuring · Miscellaneous
Merger1 fact ▸
  • Merger, 8 september 2010
05-02
State Gazette act Restructuring · Miscellaneous
Merger1 fact ▸
  • Merger, 29 september 2009
2006
13-11
State Gazette act Restructuring
Merger · Purpose change · Statutes amendment6 facts ▸
  • General meeting, 28/09/2006
  • Merger
  • Purpose change, - Het verdelen van geneesmiddelen en verzorgingsproducten voor dieren onder eigen merk; - De oprichting, de uitbating en het overnemen van groothandelverdelers…
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
13-07
State Gazette act Restructuring · Miscellaneous
Merger1 fact ▸
  • Merger, 25/06/2006
24-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital5 facts ▸
  • General meeting, 30.03.2006
  • Capital increase, €120.455,37
  • Capital increase, €879.544,63
  • Capital, €1.682.400
  • Statutes amendment
2005
28-11
State Gazette act Resignation: Starr Consult (director)
Appointments: Jeroen Bastijns (director) and Maarten Lejaeghere (director) · Reappointment: Chris Cardon (gedelegeerd bestuurder) · Registered-office move7 facts ▸
  • General meeting, 23/08/2005
  • Registered-office move, Autobaan 22, bus 00.01, 8210 Zedelgem (Loppem)
  • Director resignation, Starr Consult (director)
  • Director appointment, Jeroen Bastijns (director)
  • Director appointment, Maarten Lejaeghere (director)
  • Director reappointment, Chris Cardon (gedelegeerd bestuurder)
  • Director reappointment, Chris Cardon (chair of the board)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
37 of 37 acts read

Directors · office · real estate

Directors
2 directors, no change since 2024

Board 2

Christopher Brewster
Director · since 30-06-2023
Current
Jennifer Winter
Director · since 23-04-2024
Current
10 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Chris Cardon
Chair of the board · since 23-08-2005
Not recently confirmed
Maarten Lejaeghere
Director · since 23-08-2005
Not recently confirmed
Finipan
Director · since 14-06-2013 · Legal entity · perm. rep.: Joost Van Cauwenberge
Not recently confirmed
SAM SABBE
Director · since 08-10-2013 · Legal entity
Not recently confirmed
Asara
Director · since 13-07-2017 · Private limited company · perm. rep.: Walter BEYERS
Not recently confirmed
BUSINESS CONTACT INTERNATIONAL
Director · since 13-07-2017 · Private limited company · perm. rep.: Jeroen BASTIJNS
Not recently confirmed
F.F.F.
Director · since 13-07-2017 · Legal entity · perm. rep.: Christiaan CARDON
Not recently confirmed
Chris BREWSTER
Director · since 01-12-2017
Not recently confirmed
Jenny Winter
Director · since 01-11-2018
Not recently confirmed
Sara MADDENS
Director · since 14-06-2019
Not recently confirmed

Day-to-day management 1

Chris Cardon
Gedelegeerd bestuurder · since 23-08-2005
Not recently confirmed

Permanent representatives 4

Joost Van Cauwenberge
Permanent representative · since 14-06-2013 · for Finipan
Not recently confirmed
Christiaan CARDON
Permanent representative · since 13-07-2017 · for F.F.F.
Not recently confirmed
Jeroen BASTIJNS
Permanent representative · since 13-07-2017 · for BUSINESS CONTACT INTERNATIONAL
Not recently confirmed
Walter BEYERS
Permanent representative · since 13-07-2017 · for Asara
Not recently confirmed

Statutory auditor 1

GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
Statutory auditor · since 02-12-2024 · perm. rep.: Elie Janssens
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Oostkamp · 1 establishment unit since 2002
seat establishment The establishment unit on the map
Ground area
4,869 m²
Building footprint
4,901 m²
Volume, LiDAR
43,255 m³
Parcel 31022A0108/00K002, Flanders · tallest building 12.9 m, ±3 floors. Linked by address, not a title deed.
21 companies at this address See who is registered here
1 establishment unit
ECUPHAR
Legeweg 157, 8020 OostkampNACE 2442105
since 20022.095.887.512
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31022A0108/00K002 Flanders 4,869 m² 1 · 4,901 m² 12.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

29 people since 2005, 13 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Christopher Brewster
  • Director, from 30-06-2023 to date
Jennifer Winter
  • Director, from 23-04-2024 to date
GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
  • Statutory auditor, from 02-12-2024 to date
Chris Cardon
  • Chair of the board, already before 23-08-2005 not ended, last confirmed 28-11-2005
  • Gedelegeerd bestuurder, already before 23-08-2005 not ended, last confirmed 28-11-2005
Maarten Lejaeghere
  • Director, from 23-08-2005 not ended, last confirmed 28-11-2005
Finipan
  • Director, from 14-06-2013 not ended, last confirmed 27-11-2013
SAM SABBE
  • Director, already before 08-10-2013 not ended, last confirmed 27-11-2013
BUSINESS CONTACT INTERNATIONAL
  • Director, from 24-11-2015 not ended, last confirmed 04-08-2017
Asara
  • Director, from 13-07-2017 not ended, last confirmed 04-08-2017
F.F.F.
  • Director, from 13-07-2017 not ended, last confirmed 04-08-2017
Chris BREWSTER
  • Director, from 01-12-2017 not ended, last confirmed 29-12-2017
Jenny Winter
  • Director, from 01-11-2018 not ended, last confirmed 02-01-2019
Sara MADDENS
  • Director, from 14-06-2019 not ended, last confirmed 26-08-2019
PricewaterhouseCoopers Reviseurs d'Entreprises
  • Statutory auditor, from 12-06-2015 to 02-12-2024
MADDENS Sara Tina
  • Director, until 31-07-2020
F.F.F. BVBA
  • Director, until 24-07-2019
Business Contact International BVBA
  • Director, until 14-06-2019
Iain David MENNEER
  • Director, from 13-07-2017 to 26-04-2018
BELLEVUE
  • Director, from 24-11-2015 to 13-07-2017
Michael Schenck
  • A bestuurder, from 31-08-2016 to 13-07-2017
MYLECKE MANAGEMENT, ART & INVEST
  • Director, from 24-11-2015 to 13-07-2017
  • Chair of the board, from 31-08-2016 ended, last mentioned 23-09-2016
ALYCHLO
  • Chair of the board, from 24-11-2015 to 23-08-2016
  • Director, from 24-11-2015 to 23-08-2016
CARDON Christiaan
  • Director, already before 23-08-2011 to 29-12-2015
  • Managing director, from 23-08-2011 ended, last mentioned 27-11-2013
Jeroen BASTIJNS
  • Director, from 23-08-2005 to 29-12-2015
SAM SABBE
  • Director, until 24-11-2015
BVBA Van Cauter -Saeys & Co
  • Statutory auditor, from 27-06-2013 to 12-06-2015
Finipan NV
  • Director, until 12-06-2015
Tom Almey
  • Director, until 01-01-2011
Starr Consult
  • Director, until 28-11-2005
See the board, name and seat on a given date →

Articles of association

Purpose
De vennootschap heeft tot voorwerp, voor eigen rekening evenals voor rekening van derden, zowel in België als in het buitenland: - Het leiden, beheren en besturen van andere…
Full purpose

De vennootschap heeft tot voorwerp, voor eigen rekening evenals voor rekening van derden, zowel in België als in het buitenland: - Het leiden, beheren en besturen van andere vennootschappen ... - De aankoop, verkoop en ruiling ... - Het verwerven en aanhouden van participaties ... - Het uitbaten van apotheken ... - De studie van, verkoop van ... homeopatische producten ... - De invoer, de uitvoer ... - Het drukken en verspreiden ... - Het klaarmaken en bereiden ... - Het stimuleren, de planning ... - Alle studiën en operaties met betrekking tot alle onroerende goederen ... - Het verstrekken van adviezen ... - Het verdelen van geneesmiddelen ... - De oprichting, de uitbating ... - Handel en fabricatie ... - Het ondernemen van industriële, klinische ... analyses. - Elke handelsbedrijvigheid die met de gezondheidszorg ... - De studie, de uitbating ... van brevetten ...

Structure & network

Owners and holdings

1 owner · 9 holdings

Chain of control

  1. ANIMALCARE GROUP PLCGB consolidated
  2. ECUPHAR

Highest known parent: ANIMALCARE GROUP PLC (United Kingdom). The sources do not say who stands above it.

Owners 1

  • ANIMALCARE GROUP PLCGBparent
    consolidated

Holdings 9

  • ANIMALCARE LTDGBsubsidiary
    Equity GBP 16.6mResult GBP 22.0m
    100%
  • BELPHAR LDAPTsubsidiary
    Equity €1.1mResult €550,306
    100%
  • Ecuphar B.V.NLsubsidiary
    Equity €376,903Result €306,710
    100%
  • Ecuphar GmbHDEsubsidiary
    Equity €2.9mResult €352,757
    100%
  • ECUPHAR ITALIAITsubsidiary
    Equity €1.1mResult €449,831
    100%
  • ECUPHAR VETERINARIA SLUESsubsidiary
    Equity €7.4mResult €2.8m
    100%
  • ECUPHAR VETERINARY PRODUCTSNLsubsidiary
    Equity -€77,537Result -€7,562
    100%
  • EURACON PHARMA CONSULTING UND TRADINGDEsubsidiary
    Equity -€18,348Result €33,101
    100%
  • OrnisFRsubsidiary
    Equity €37,910Result -€795
    100%

According to the 2025 annual accounts of ECUPHAR and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

7 connected companies
Linked via shared directors
CWS WORKWEAR BELGIE
Shared director
→
FAGRON
Shared corporate director
→
PAIRI DAIZA
Shared corporate director
→
Perrigo Holding
Shared corporate director
→
Show 3 more companies with a shared director
ROYAL SPORTING CLUB ANDERLECHT
Shared corporate director
→
Smartphoto group
Shared corporate director
→
VERSLUYS INVEST
Shared corporate director
→

Acquisitions and mergers

3 transactions
Took over:EQUIPHARMA
BE 0460.837.892silent merger · proposal · State Gazette act of 10-12-2010 (3 acts) · effective 08-09-2010
Took over:Ecuphar
State Gazette act of 13-11-2006
Took over:ECUPHAR
BE 0446.897.212proposal · State Gazette act of 13-07-2006

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 07-12-2015 ↗
After the capital increase act of 06-08-2015 ↗
  • MC3 Health
  • Bert VANHEULE
  • Martin AMEYE
  • Jan DIRIX
  • Godelieve HANSSENS
  • Wim CROMMELYNCK
After the capital increase act of 12-06-2012 ↗
After the capital increase act of 04-07-2011 ↗
After 2 capital increases act of 24-04-2006 ↗
  • Huwgemeenschap Niville-Van Hecke 621 shares

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 08-09-2020 Capital stated in the act · 12,967,260.46 EUR · 19,982,555 shares
  2. 04-08-2017 Capital increase of 3,909,690.46 EUR · to 12,967,260.46 EUR · in kind
  3. 22-08-2016 Capital stated in the act · 9,057,570 EUR
  4. 07-12-2015 Capital increase of 53,250 EUR · to 9,057,570 EUR · 60 new shares
  5. 06-08-2015 Capital increase of 2,850,000 EUR · to 9,004,320 EUR
  6. 03-04-2013 Capital reduction of 6,039,280 EUR · to 6,154,320 EUR · repaid to the shareholders
  7. 06-08-2012 Capital reduction of 6,039,280 EUR · to 6,154,320 EUR · repaid to the shareholders
  8. 12-06-2012 Capital increase of 273,350 EUR · to 12,193,600 EUR · 308 new shares
Show 3 older capital entries
  1. 04-07-2011 Capital increase of 237,850 EUR · to 11,920,250 EUR · 268 new shares
  2. 24-04-2006 Capital increase of 120,455.37 EUR · to 802,855.37 EUR · 621 new shares
  3. 24-04-2006 Capital increase of 879,544.63 EUR · to 1,682,400 EUR · no new shares

Recognitions · licences · registrations

Food safety, FASFC

1 site
Oostkamp2.095.887.512
3 permissions
Groothandelaar grondstoffen · since 01-12-2021
Toelating · Groothandelaar mengvoeders · since 17-07-2008
Groothandelaar petfood · since 07-07-2008

Legal Entity Identifier

894500T8UTWZECDM5T83
live in the LEI register

Similar companies · same sector, comparable size

Of 13,417 companies in sector 73300 we hold annual accounts for 6,899. 63 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded06-12-2001
Fiscal year end31-12
Trade name NL Cardon Pharmaceuticals
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
73300Public relations and communication consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0476255350
Also 9925:BE0476255350
Registered 09-04-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.